PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 21052690-8 2011 We found a significantly higher risk for LASM in patients carrying the caspase-1 (CASP1) 5352 A allele (RR = 2.32; 95% CI 1.22-4.42). lasm 41-45 caspase 1 Homo sapiens 71-80 21052690-8 2011 We found a significantly higher risk for LASM in patients carrying the caspase-1 (CASP1) 5352 A allele (RR = 2.32; 95% CI 1.22-4.42). lasm 41-45 caspase 1 Homo sapiens 82-87 21052690-11 2011 In conclusion, carriers of the 5352 A allele in the caspase-1 gene are at increased risk of developing LASM after SES implantation. lasm 103-107 caspase 1 Homo sapiens 52-61 9342758-6 1997 Cytokine secretion capacity was significantly altered in LASM which exhibited reduced TNF alpha and IL-6, but elevated IL-1 alpha secretion when compared to control SM. lasm 57-61 tumor necrosis factor Homo sapiens 86-95 9342758-6 1997 Cytokine secretion capacity was significantly altered in LASM which exhibited reduced TNF alpha and IL-6, but elevated IL-1 alpha secretion when compared to control SM. lasm 57-61 interleukin 6 Homo sapiens 100-104 9342758-6 1997 Cytokine secretion capacity was significantly altered in LASM which exhibited reduced TNF alpha and IL-6, but elevated IL-1 alpha secretion when compared to control SM. lasm 57-61 interleukin 1 alpha Homo sapiens 119-129